A man with depression staring down

See if you may qualify for Relmada’s depression study

The Relight clinical research program is testing an investigational medication for people living with Major Depressive Disorder (MDD).

Little interest or pleasure in doing things?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Feeling down, depressed, or hopeless?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Trouble falling or staying asleep, or sleeping too much?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Feeling tired or having little energy?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Poor appetite or overeating?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Feeling bad about yourself - or that you are a failure or have let yourself or your family down?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Trouble concentrating on things, such as reading the newspaper or watching television?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

Thoughts that you would be better off dead, or of hurting yourself in some way?

Not at allSeveral daysMore than half the daysNearly every day

The copyright for this questionnaire, called PHQ-9, was formerly held by Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it ¹. No permission is required to reproduce, translate, display or distribute the PHQ-9.

1.

Kroenke K, Spitzer RL, Williams JB; The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep 16(9):606-13

We sincerely thank you for your interest in the Relmada studies.

Based on the answers provided, this study may not be suitable for you at this time. Please talk to your doctor if you feel this response is in error, or to see if other clinical trials might be a better fit for you.

Back to Relmada Studies homepage

Thank you for your interest in the Relmada Studies.

Based on the answers provided, you may qualify to participate in the study, we would like to speak to you to refer you to a participating center. Please complete the form below so we can contact you.

Please do not provide any medical, health or other sensitive personal information in your submission. You may also choose to email clinicaltrials@relmada.com directly if you prefer. Personal information submitted through this website is subject to our Privacy Policy. By submitting the form below, you acknowledge that you have read and understand our privacy policy.

(*) The request will be handled by our clinical service provider

Thank you,
‍

Name

.
‍

We received your message and contact information, the Relmada Study team will reach out to you within two days. We are looking forward to connecting with you!

Oops! Something went wrong while submitting the form.

Points:

0